Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Id and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma: a Prospective, Randomized, Controlled, Multicenter Clinical Study

NCT05477797 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT05477797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05477797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Id and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma: a Prospective, Randomized, Controlled, Multicenter Clinical Study
Lead sponsor
RenJi Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
February 16, 2023
Completion date
January 15, 2026
Enrollment
420 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

maintenance, overall survival, progression free survival